Akt2 Regulates Metastatic Potential in Neuroblastoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Qiao, Jingbo ^a   Lee, Sora ^a,b   Paul, Pritha ^a,b   Qiao, Lan ^a   Taylor, Chase J ^a   Schlegel, Cameron ^a   Colon, Nadja C ^a   Chung, Dai H ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; MYC PROTEIN; PROTEIN KINASE B BETA; PROTEIN KINASE B INHIBITOR; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, MYC; HUMANS; LIVER NEOPLASMS; MALE; MICE; NEOPLASM METASTASIS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84874499416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056382     Document Type: Article

References (22)

1. Gustafson WC, De Berry BB, Evers BM, Chung DH, (2005) Role of gastrointestinal hormones in neuroblastoma. World J Surg 29: 281-286.
2. Kim S, Hu W, Kelly DR, Hellmich MR, Evers BM, et al. (2002) Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg 235: 621-629; discussion 629-630.
3. Ishola TA, Kang J, Qiao J, Evers BM, Chung DH, (2007) Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells. Biochim Biophys Acta 1770: 927-932.
4. Kang J, Ishola TA, Baregamian N, Mourot JM, Rychahou PG, et al. (2007) Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett 253: 273-281.
5. Qiao J, Kang J, Cree J, Evers BM, Chung DH, (2005) Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas. Ann Surg 241: 684-691; discussion 691-682.
6. Opel D, Poremba C, Simon T, Debatin KM, Fulda S, (2007) Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 67: 735-745.
7. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, et al. (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16: 259-266.
8. Dummler B, Hemmings BA, (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35: 231-235.
9. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, et al. (2003) Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res 63: 196-206.
10. Altomare DA, Tanno S, De Rienzo A, Klein-Szanto AJ, Tanno S, et al. (2002) Frequent activation of AKT2 kinase in human pancreatic carcinomas. J Cell Biochem 87: 470-476.
11. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, et al. (2007) Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 1979-1987.
12. Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, et al. (2008) Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A 105: 20315-20320.
13. Qiao J, Kang J, Ishola TA, Rychahou PG, Evers BM, et al. (2008) Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc Natl Acad Sci U S A 105: 12891-12896.
14. Gustafson WC, Weiss WA, (2010) Myc proteins as therapeutic targets. Oncogene 29: 1249-1259.
15. Maris JM, (2010) Recent advances in neuroblastoma. N Engl J Med 362: 2202-2211.
16. Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M, (1998) Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol 16: 3286-3294.
17. Kang J, Rychahou PG, Ishola TA, Mourot JM, Evers BM, et al. (2008) N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma. Oncogene 27: 3999-4007.
18. Chanthery YH, Gustafson WC, Itsara M, Persson A, Hackett CS, et al. (2012) Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma. Sci Transl Med 4: 115ra113.
19. Misawa A, Hosoi H, Arimoto A, Shikata T, Akioka S, et al. (2000) N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res 60: 64-69.
20. Gonzalez E, McGraw TE, (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8: 2502-2508.
21. Riley RD, Heney D, Jones DR, Sutton AJ, Lambert PC, et al. (2004) A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 10: 4-12.
22. Foley NH, Bray IM, Tivnan A, Bryan K, Murphy DM, et al. (2010) MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol Cancer 9: 83.